GlobeNews Wire

LEA Raises $1.25M to Power Client Data Automation Across the Wealth Management Industry

Social Leverage backs LEA’s mission to eliminate manual document work and quickly deliver clean data to core systems firms rely…

7 months ago

Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030

September 08, 2025 17:57 ET  | Source: Harrow, Inc. NASHVILLE, Tenn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider…

7 months ago

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Wayrilz (rilzabrutinib)

LOUISVILLE, Ky., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a…

7 months ago

NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness

TORONTO and HAIFA, Israel, Sept. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone”…

7 months ago

ACM Research Delivered Its First High-Throughput Ultra Lith KrF Track System to a Leading Chinese Logic Wafer Fab Customer

September 07, 2025 20:00 ET  | Source: ACM Research, Inc. New Ultra Lith KrF Track System Delivers High-Throughput Performance with…

7 months ago

DataGlobal Hubs GDAI 2025 Showcases the Worlds Brightest Minds in Data and AI

PHOENIX, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Global Data & AI Virtual Tech Conference (GDAI 2025), the biggest virtual tech…

7 months ago

DIH Holding US, Inc. Receives Nasdaq Staff Determination Letter

September 05, 2025 16:30 ET  | Source: DIH Holding US, Inc. DIH Receives Notice for Continued Deficiency and Delist Letter…

7 months ago

InnoCare Announces Approval of HIBRUKA (Orelabrutinib) for the Treatment of Marginal Zone Lymphoma in Singapore

BEIJING, Sept. 07, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer…

7 months ago

Dianthus Therapeutics to Host Conference Call and Webcast to Discuss Results from Phase 2 MaGic Trial of Claseprubart (DNTH103) in Generalized Myasthenia Gravis

September 07, 2025 18:25 ET  | Source: Dianthus Therapeutics, Inc. NEW YORK and WALTHAM, Mass., Sept. 07, 2025 (GLOBE NEWSWIRE)…

7 months ago

KFSHRC to Partake Tomorrow as Strategic Partner in C3 Davos of Healthcare New York Summit

NEW YORK, Sept. 07, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) will participate tomorrow (Monday)…

7 months ago